MO - Altria Group, Inc.
53.48 +0.15 (0.28%)
After hours: 6:57PM EST
| Previous Close | 53.95 |
| Open | 54.44 |
| Bid | 53.48 x 900 |
| Ask | 53.60 x 1400 |
| Day's Range | 53.17 - 54.89 |
| 52 Week Range | 52.73 - 74.38 |
| Volume | 9,310,723 |
| Avg. Volume | 8,781,854 |
| Market Cap | 100.21B |
| Beta (3Y Monthly) | -0.14 |
| PE Ratio (TTM) | 9.47 |
| EPS (TTM) | 5.63 |
| Earnings Date | Jan 30, 2019 - Feb 4, 2019 |
| Forward Dividend & Yield | 3.20 (5.91%) |
| Ex-Dividend Date | 2018-09-13 |
| 1y Target Est | 65.09 |
- CNBC Videos•yesterday
Canopy Growth best way to play Canadian cannabis
Jim Cramer continues to back Canopy Growth Corp. as the best way to invest in the growing Canadian cannabis space after tobacco giant Altria invests in its rival, Cronos Group.
- CNBC Videos•yesterday
Canopy Growth still best way to play Canadian cannabis ev...
Jim Cramer continues to back Canopy Growth Corp. as the best way to invest in the growing Canadian cannabis space after tobacco giant Altria invests in its rival, Cronos Group.
- Business Wire•7 hours ago
Altria Declares Regular Quarterly Dividend of $0.80 per Common Share
Altria Group, Inc. today announced that its Board of Directors declared a regular quarterly dividend of $0.80 per common share, payable on January 10, 2019, to shareholders of record as of December 26, 2018.
- InvestorPlace•14 hours ago
Will Coca-Cola Stock Be the Next Giant to Fall?
From here, Coca-Cola (NYSE:KO) looks badly overvalued. Coca-Cola stock is a classic long-term play, seemingly, but that alone doesn’t justify a stretched valuation. KO stock touched an all-time high just a couple of weeks ago.
- Market Realist•10 hours ago
Altria and Philip Morris: Do Dividend Yields Look Attractive?
Will 2019 Be Better for Altria and Philip Morris? Dividends help smooth out return volatility for shareholders. Both Philip Morris International (PM) and Altria Group (MO) have a strong history of returning cash to shareholders.
- Market Realist•11 hours ago
What to Expect from Philip Morris’s Revenue in 2019
Analysts expect Philip Morris International’s (PM) revenue to rise by 2.7% to $29.54 billion in 2018. They expect the company’s revenue for 2019 to be at $30.33 billion, which represents YoY growth of 2.7% from 2018.
- Motley Fool•12 hours ago
3 Dividend Stocks That Pay You More Than Exxon Does
Looking for big yield? ExxonMobil has it, but these three stocks should also be on your radar.
- GlobeNewswire•12 hours ago
Metrospaces (OTC:MSPC) Seize Upon Real Estate Market Opportunities in the Cannabis Space; Companies discussed: Aurora Cannabis, Cronos Group, Inc., Altria, Crop Infrastructure Corp.
Investorideas.com, a leading investor news resource covering real estate and cannabis stocks, releases a snapshot looking at the synergistic opportunity for both sectors. As the emerging cannabis market explodes with increased legalization across North American markets, Metrospaces, Inc. (OTC:MSPC) Company Executive President Mr. Oscar Brito highlights the considerable market opportunities in real estate that many investors may have overlooked.
- Market Realist•13 hours ago
Why Are Analysts Expecting Altria’s Revenue to Rise in 2019?
Will 2019 Be Better for Altria and Philip Morris? Analysts are expecting Altria Group’s (MO) revenue to rise by 0.9% to $19.66 billion in 2018, while its revenue in 2019 is expected to increase by 1.5% to $19.95 billion. What will drive Altria’s sales?
- Barrons.com•14 hours ago
Altria Might Have a Plan for a Cigarette-Free Future
Altria’s announcement that it would invest in Canadian marijuana company Cronos Group got all the attention, but one analyst describes its decision to discontinue its own vaping products as “savvy.”
- CNBC•yesterday
Cramer Remix: Don't waste your time with sector-based ETFs
Jim Cramer uses the tech sector to make a case for picking individual stocks over risky exchange-traded funds.
Zacks•yesterdayAltria (MO) Gains As Market Dips: What You Should Know
Altria (MO) closed the most recent trading day at $53.95, moving +1.11% from the previous trading session.
- CNBC•yesterday
Canopy Growth still best way to play Canadian cannabis even with Cronos-Altria deal: Cramer
Jim Cramer continues to back Canopy Growth Corp. as the best way to invest in the growing Canadian cannabis space after tobacco giant Altria invests in its rival, Cronos Group.
- Market Realist•yesterday
Altria Beats Philip Morris’s EPS Growth in First Three Quarters
Will 2019 Be Better for Altria and Philip Morris? In the first three quarters of 2018, Altria Group (MO) posted adjusted EPS of $3.04, which represents growth of 22.6% from $2.48 in the corresponding three quarters of the previous year. Also, the company has outperformed analysts’ EPS expectations in all three quarters.
- Motley Fool•yesterday
Why New Age Beverages Stock Spiked Today
Shares of the CBD beverage maker picked up steam for the second day in a row. Here's why.
Zacks•yesterdayCanopy Growth (CGC) Gains on Hemp Legalization, Institutional Interest
Shares of Canopy Growth (CGC) were up more than 6% in late afternoon trading Tuesday, as investors expressed optimism about the Senate's hemp legalization bill and management's comments about interest from institutional investors.
- Market Realist•yesterday
Philip Morris Has Outperformed Altria’s Revenue Growth in 2018
Will 2019 Be Better for Altria and Philip Morris? In the first three quarters of 2018, Philip Morris International (PM) posted net revenue growth of 8.2%, outperforming Altria Group’s (MO) net revenue growth of 0.4%. During the period, Philip Morris posted net revenue of $22.13 billion compared to $20.45 billion in the first three quarters of 2017.
- Kiplinger•yesterday
12 Stocks You Should Never Sell
Hopping in and out of stocks tends to do more harm than good to your portfolio. Fortunately, most of the time, investors are content to sit back and let time do the heavy lifting. Every now and then, however, an uninterrupted market-wide rally (such as the one we saw in 2017) followed by a couple of major corrections (such as the ones we've seen in 2018) inspires a more active approach. Buying every dip last year was a bulletproof strategy; steering clear of this year's big dips would've left most investors far better off. But broadly speaking, investors shouldn't embrace that short-term mindset. Buy-and-hold is a time-tested strategy that helps investors avoid trying to time the market (which even experts can't reliably do) and making poor emotional decisions. With that as a backdrop, here are a dozen stocks to never sell. Many buy-and-holders are looking to reset their portfolios as the new year begins. If you hold any of the stocks, don't stop ... and if you're looking to buy, be ready to commit. Each company has plenty to success that their history of success should continue for years to come. And each operates in an industry that won't go away anytime soon. SEE ALSO: 101 Best Dividend Stocks to Buy for 2019 and Beyond
- InvestorPlace•yesterday
Did Altria Pay Too Much for Cronos Stock?
Altria Group (NYSE:MO) is joining the mega-cap firms eager to hedge against a potential decline in their home business. On Dec. 7, the firm said it would invest a $1.8 billion stake in Cronos Group (NASDAQ:CRON). Meanwhile, Constellation Brands (NYSE:STZ) bought Canopy Growth (NYSE:CGC) at the beginning of this year.
- Market Realist•yesterday
Can We Expect Upward Momentum in Altria and Philip Morris?
Will 2019 Be Better for Altria and Philip Morris? 2018 has been tough for tobacco companies. The increased anti-tobacco regulations, the declining smoking population, and the rising competition in the RRP (reduced-risk products) space have been putting pressure on tobacco companies.
Markit•yesterdaySee what the IHS Markit Score report has to say about Altria Group Inc.
Altria Group Inc NYSE:MO
- Motley Fool•2 days ago
Altria Grossly Overpaid for Its Equity Stake in Pot Stock Cronos Group
Ponying up $1.8 billion for a 45% stake in Cronos could come back to haunt the maker of Marlboro cigarettes.
- ACCESSWIRE•2 days ago
Stock Market Press Spotlight on Under-Served Multi-Billion Dollar Cannabis Real Estate Market: Metrospaces, Inc. (OTC: MSPC), Altria Group (NYSE: MO) and Tilray (NASDAQ: TLRY)
NEW YORK, NY / ACCESSWIRE / December 11, 2018 / Metrospaces, Inc. (OTC PINK: MSPC) is high atop Stock Market Press' list of companies targeting the highly lucrative cannabis real estate market. A major shift is taking place in the tobacco industry, as seen with the recent Altria (MO) acquisition of 45% of Cronos (NASDAQ listed) stock, turning tobacco into cannabis farmland. Altria announces $2.4B investment deal with Canadian cannabis company Cronos.
Zacks•2 days agoThe Zacks Analyst Blog Highlights: Altria, Cronos, Constellation, Canopy Growth and ETFMG Alternative Harvest
The Zacks Analyst Blog Highlights: Altria, Cronos, Constellation, Canopy Growth and ETFMG Alternative Harvest
- InvestorPlace•2 days ago
4 Reasons Why Aphria Stock Could Be an M&A Target Next
Despite broader market turmoil, the cannabis sector is starting to heat up again thanks to M&A activity. First it was Canopy Growth (NYSE:CGC), then Cronos (NASDAQ:CRON), and I think the next target is going to be Aphria (NYSE:APHA) stock. Now, everyone is again bidding up pot stocks in an attempt to find the next M&A target, which leads us to Aphria.
